The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Preferential Modification of Nuclear Proteins by a Novel Ubiquitin-like Molecule
Open accessAbstract
Sentrin is a novel ubiquitin-like protein that protects cells against both anti-Fas and tumor necrosis factor-induced cell death. Antiserum recognizing the N terminus of sentrin revealed the presence of a 18-kDa sentrin monomer, a 90-kDa band (p90), and multiple high molecular mass bands. Because sentrin possesses the conserved Gly-Gly residues near the C terminus, it is likely that these additional bands represent conjugation of sentrin to other proteins in a manner that is similar to the ubiquitination pathway. Transient expression of hemagglutinin epitope-tagged sentrin mutants in COS cells demonstrated that the sentrin C terminus is cleaved, which allows it to be conjugated to other proteins via the conserved C-terminal Gly residue. Immunocytochemical staining and cell fractionation analysis demonstrated that sentrin monomer is localized predominantly to the cytosol. However, p90 and the majority of sentrinized proteins appeared to be localized to the nucleus. When the conserved Gly-Gly residues of sentrin were changed to Gly-Ala, only sentrin monomer and p90 but not the high molecular mass bands were observed. Thus, p90 generation appears to be required for the formation of high molecular mass bands in the nucleus. Taken together, sentrinization represents a novel pathway for nuclear protein modification, which is distinct from ubiquitination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Cited by
Johnson, E. S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074118 · Cited by 1,675
The ubiquitin-proteasome pathway: on protein death and cell life
Ciechanover, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7151 · Cited by 1,426
SUMO-1 Modification of IκBα Inhibits NF-κB Activation
Desterro, J. M. P., Rodriguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,038
Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3
Saitoh, H., & Hinchey, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6252 · Cited by 895
Sumo, ubiquitin's mysterious cousin
Müller, S., Hoege, C., Pyrowolakis, G., & Jentsch, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056591 · Cited by 764
SUMO-1 Conjugation in Vivo Requires Both a Consensus Modification Motif and Nuclear Targeting
Rodriguez, M. S., Dargemont, C., & Hay, R. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009476200 · Cited by 744
SUMO-1 modification activates the transcriptional response of p53
Rodriguez, M. S., Desterro, J. M. P., Lain, S., Midgley, C. A., Lane, D. P., & Hay, R. T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6455 · Cited by 639
Johnson, E. S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5509 · Cited by 553
Characterization of NEDD8, a Developmentally Down-regulated Ubiquitin-like Protein
Kamitani, T., Kito, K., Nguyen, H. P., & Yeh, E. T. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28557 · Cited by 535
Self-citationA comprehensive compilation of SUMO proteomics
Hendriks, I. A., & Vertegaal, A. C. O. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.81 · Cited by 514
A New Protein Conjugation System in Human
Mizushima, N., Sugita, H., Yoshimori, T., & Ohsumi, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.33889 · Cited by 513
Ubc9p Is the Conjugating Enzyme for the Ubiquitin-like Protein Smt3p
Johnson, E. S., & Blobel, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26799 · Cited by 500
Ubiquitin-like proteins: new wines in new bottles
Yeh, E. T. H., Gong, L., & Kamitani, T. (2000) · Gene · doi:10.1016/s0378-1119(00)00139-6 · Cited by 469
Self-citationMatunis, M. J., Wu, J., & Blobel, G. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.3.499 · Cited by 464
Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1)
Poukka, H., Karvonen, U., Jänne, O. A., & Palvimo, J. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14145 · Cited by 457
Structure determination of the small ubiquitin-related modifier SUMO-1
Bayer, P., Arndt, A., Metzger, S., Mahajan, R., Melchior, F., Jaenicke, R., & Becker, J. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1839 · Cited by 445
Apg16p is required for the function of the Apg12p–Apg5p conjugate in the yeast autophagy pathway
Mizushima, N., Noda, T., & Ohsumi, Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3888 · Cited by 437
A novel protein‐conjugating system for Ufm1, a ubiquitin‐fold modifier
Komatsu, M., Chiba, T., Tatsumi, K., Iemura, S., Tanida, I., Okazaki, N., Ueno, T., Kominami, E., Natsume, T., & Tanaka, K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600205 · Cited by 417
Everett, R. D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M., & Parkinson, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6581-6591.1998 · Cited by 402
Covalent Modification of p73α by SUMO-1
Minty, A., Dumont, X., Kaghad, M., & Caput, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004293200 · Cited by 388
Lonergan, K. M., Iliopoulos, O., Ohh, M., Kamura, T., Conaway, R. C., Conaway, J. W., & Kaelin, W. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.732 · Cited by 381
Identification of the Enzyme Required for Activation of the Small Ubiquitin-like Protein SUMO-1
Desterro, J. M. P., Rodriguez, M. S., Kemp, G. D., & Hay, R. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10618 · Cited by 380
Ubch9 conjugates SUMO but not ubiquitin
Desterro, J. M. P., Thomson, J., & Hay, R. T. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01305-7 · Cited by 365
Chang, H.-M., & Yeh, E. T. H. (2020) · Physiological Reviews · doi:10.1152/physrev.00025.2019 · Cited by 355
Self-citationSternsdorf, T., Jensen, K., & Will, H. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.7.1621 · Cited by 331
Circadian Clock Control by SUMOylation of BMAL1
Cardone, L., Hirayama, J., Giordano, F., Tamaru, T., Palvimo, J. J., & Sassone-Corsi, P. (2005) · Science · doi:10.1126/science.1110689 · Cited by 329
Small Ubiquitin-like Modifier (SUMO) Modification of Natively Unfolded Proteins Tau and α-Synuclein
Dorval, V., & Fraser, P. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510127200 · Cited by 319
Duprez, E., Saurin, A. J., Desterro, J. M., Lallemand-Breitenbach, V., Howe, K., Boddy, M. N., Solomon, E., Thé, H. D., Hay, R. T., & Freemont, P. S. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.3.381 · Cited by 312
Identification of Three Major Sentrinization Sites in PML
Kamitani, T., Kito, K., Nguyen, H. P., Wada, H., Fukuda-Kamitani, T., & Yeh, E. T. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26675 · Cited by 310
Self-citationMahajan, R., Gerace, L., & Melchior, F. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.2.259 · Cited by 289
Differential Regulation of Sentrinized Proteins by a Novel Sentrin-specific Protease
Gong, L., Millas, S., Maul, G. G., & Yeh, E. T. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3355 · Cited by 279
Self-citationParkinson, J., Lees-Miller, S. P., & Everett, R. D. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.650-657.1999 · Cited by 253
Shao, R., Zhang, F.-P., Tian, F., Anders Friberg, P., Wang, X., Sjöland, H., & Billig, H. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.05.079 · Cited by 149
Hirano, Y., Murata, S., Tanaka, K., Shimizu, M., & Sato, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212448200 · Cited by 110
Metadata
- Authors
- Kamitani, T., Nguyen, H. P., & Yeh, E. T. H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-05
- Volume
- 272
- Issue
- 22
- Pages
- 14001-14004
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2080101736
- Cited by
- 175
- References
- 1
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.